As Global Heatwaves Intensify, Kolmar Korea Brings Cooling Innovation to Sunscreen
Kolmar Korea advances K-sun care with non-menthol cooling ingredients, water-drop technology, and a high-moisture Jelly Sun Stick New cooling formulations lower skin temperature by approximately 4–6°C while delivering robust UV protection SEOUL,...
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.93 Million Tokens, and Total Crypto and Total Cash Holdings of $15.7 Billion
Bitmine owns 4.9% of the total ETH coin supply of 122.0 million Bitmine is 97% of the way to the 'Alchemy of 5%' in just 15 months Crypto equities are largest contributor to Russell 1000 quarter to date, representing 4 of the top 21 stocks Bitmine...
Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo
NEW YORK and SUZHOU, China, Sept. 8, 2026 /PRNewswire/ -- Accro Bioscience (Suzhou) Limited ("Accro") today announced that Shanghai Fosun Pharmaceutical Industrial Development Company Limited ("Fosun Pharma Industrial"), a subsidiary of its partner...
HBM9378/WIN378, an Ultra-Long-Acting Antibody Targeting TSLP, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study
The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. The analysis demonstrated a half-life of up to 75 days, with clinical effects consistent with...
Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy
SHANGHAI, Sept. 8, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that it has recently received clearance from the U.S. Food and...
Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results of SKB378/WIN378 in Asthma, and Initiates Phase 3 Study
The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. The analysis demonstrated a half-life of up to 75 days, with clinical effects consistent with...
Axcelis to Build New Manufacturing Facility in Pyeongtaek, Korea
BEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans to invest $35 million in its global...
CDF Corporation Launches the Squiz® System in North America, Bringing Automated Liner Evacuation to Manufacturers of Thick, High-Value Liquids
New automated system recovers high-value product left behind in IBC liners, reducing product waste by up to 96 percent in manufacturer trials PLYMOUTH, Mass., Sept. 8, 2026 /PRNewswire/ -- CDF Corporation, a manufacturer of flexible liners for...